DUBLIN, Aug. 06, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/9f2kgl/investigation) has announced the addition of the "Investigation Report on China's Cefathiamidine Market, 2010-2019" report to their offering.
Developed by Guangzhou Baiyunshan Pharmaceutical General Factory, cefathiamidine has been written into the Chinese Pharmacopoeia (2005). Ever since its marketing in 2000, the sales value of cefathiamidine has risen from less than CNY 100 million in 2005 to CNY 459 million in 2014 with CAGR during this period reaching up to 18.6%.
Despite its status as the first generation of cephalosporin, cefathiamidine's antimicrobial effect especially that on enterococcus has surpassed all other similar products. As a mature product in the clinic, cefathiamidine has been widely used for the treatment of respiratory, liver, five senses, urinary tract infections, endocarditis and sepsis.
Manufacturers of cefathiamidine focus on high-end market and emphasize products' ingenuity and outstanding quality. Currently, the cefathiamidine industry shows a high degree of market concentration. We have Guangzhou Baiyunshan Pharmaceutical General Factory, Shandong Luoxin Pharmacy Stock Co., Ltd, Shandong Lukang Pharmaceutical Co., Ltd, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd and Fuan Pharmaceutical (Group) Qingyutang Pharmaceutical Co., Ltd, among which Guangzhou Baiyunshan Pharmaceutical General Factory has the largest market share of 82.33% in 2014 for sales value. As cefathiamidine acts like Methicillin-resistant Staphylococcus aureus (MRSA) and is much safer than traditional drugs for MRSA like vancomycin, norvancomycin, teicoplanin and linezolid, it still has a market potential. The market size of cefathiamidine is expected to keep growing in the next few years in China.
Key Topics Covered:
1 Related Concepts of Cefathiamidine
2 Market Profile of Cefathiamidine in China
3 Survey on Sales Status of Cefathiamidine in China, 2010-2014
4 Survey on Market Share of Major Manufacturers of Cefathiamidine in China, 2010-2014
5 Survey on Dosage Forms of Cefathiamidine in China, 2010-2014
6 Reference Price of Cefathiamidine in Chinese Hospitals in 2014
7 Major Manufacturers of Cefathiamidine in Chinese Market, 2010-2014
8 Market Outlook of Cefathiamidine in China, 2015-2019
- Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
- Baiyunshan Pharmaceutical General Factory
- Shandong Luoxin Pharmacy Stock Co., Ltd
- Shandong Lukang Pharmaceutical Co., Ltd
- Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd
- Fuan Pharmaceutical (Group) Qingyutang Pharmaceutical Co., Ltd
For more information visit http://www.researchandmarkets.com/research/9f2kgl/investigation
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets